Shopping Cart
- Remove All
- Your shopping cart is currently empty
SB1578, also known as ONX-0805, is a novel, orally bioavailable JAK2 inhibitor with specificity for JAK2 within the JAK family and also potent activity against FLT3 and c-Fms. SB1578 blocks the activation of these kinases and their downstream signaling in pertinent cells, leading to inhibition of pathological cellular responses. The biochemical and cellular activities of SB1578 translate into its high efficacy in two rodent models of arthritis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 2.014 € | 8-10 weeks | |
50 mg | 2.641 € | 8-10 weeks | |
100 mg | 3.515 € | 8-10 weeks |
Description | SB1578, also known as ONX-0805, is a novel, orally bioavailable JAK2 inhibitor with specificity for JAK2 within the JAK family and also potent activity against FLT3 and c-Fms. SB1578 blocks the activation of these kinases and their downstream signaling in pertinent cells, leading to inhibition of pathological cellular responses. The biochemical and cellular activities of SB1578 translate into its high efficacy in two rodent models of arthritis. |
Molecular Weight | 462.54 |
Formula | C26H30N4O4 |
Cas No. | 937273-04-6 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.